B-group Vitamins Reduce Plasma Homocysteine Concentration in Patients with Type II Diabetes Mellitus and Normal Basal Homocysteine

References

• American Diabetes Association. Detection and management of lipid disorders in diabetes. Diabetes Care 1993; 16(Suppl. 2): 828–34.
   Google Scholar
• Reaven GM, Chen Y-DI. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988; 4: 639–52.
   PubMed Web of Science ®Google Scholar
• Bierman EL. Atherogenesis in diabetes. Atheroscler Thromb 1992; 12: 647–56.
   PubMed Web of Science ®Google Scholar
• Haffner SM. Lipoprotein (a) and diabetes. An update. Diabetes Care 1993; 16: 835–40.
   Google Scholar
• Colwell JA, Winocour PD, Lopes-Virella M. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 1983; 75: 67–80.
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I, Roul C, Alessi M. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetes mellitus patients: relationship with plasma insulin. Thromb Haemost 1989; 61: 370–3.
   PubMed Web of Science ®Google Scholar
• Gugliano D, Paolisso G, Geriello A. Oxidative stress and diabetic vascular complication. Diabetes Care 1996; 19: 257–67.
   Google Scholar
• Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc 1997; 277: 1775–81.
   Google Scholar
• Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 4: 1042–50.
   Google Scholar
• Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990; 1: 228–37.
   Google Scholar
• Selhub J, Jacques PF, Bostom AG et al. Relationship between plasma homocysteine, vitamin status and extracranial carotid artery stenosis in the Framingham Study population. J Nutr 1996; 126(Suppl. 4): 1258S–1265S.
   Google Scholar
• Havivi E, Bar-On H, Reshef A, Stein P. Vitamins and trace metals status in NIDDM. Int J Vitam Nutr Res 1991; 61: 328–33.
   Google Scholar
• Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999; 55: 1028–35.
   PubMed Web of Science ®Google Scholar
• Bar-On H, Kidron M, Friedlander Y et al. Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med 2000; 247: 287–94.
   Google Scholar
• Hultberg B, Agardh CD, Agardh E, Lovestam-Adrian M. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study. Scand J Clin Lab Invest 1997; 57: 595–600.
   Web of Science ®Google Scholar
• Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care 1998; 21: 841–8.
   PubMed Web of Science ®Google Scholar
• Samyn IW. Accelerated analysis of homocysteine, methionine, branched chain amino acids, tyrosine and phenylalanine for clinical diagnosis. Amino Acid Method, Pharmacia, 1997.
   Google Scholar
• Yeromenko Y, Lavie L, Levy Y. Homocysteine and cardiovascular risk in patients with diabetes mellitus. Nutr Metab Cardiovasc Dis 2001; 11: 108–16.
   Google Scholar
• Okada E, Oida K, Tada H et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type II diabetes. Diabetes Care 1999; 22: 484–90.
   Google Scholar
• Chico A, Perez A, Cordoba A. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998; 41: 684–93.
   PubMed Web of Science ®Google Scholar
• Kark JD, Selhub J, Bostom A, Adler B, Rosenberg IH. Plasma homocysteine and all-cause mortality in diabetes. Lancet 1999; 353: 1936–7.
   Google Scholar
• Lanfredini M, Fiorina P, Peca MG et al. Fasting and post-methionine load homocysteine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non- insulin dependent diabetes mellitus patients. Metabolism 1998; 47: 915–21.
   Google Scholar
• Munshi MN, Stone A, Fink L, Fonseca V. Hyperhomocysteinemia following a methionine load in patients with non-insulin dependent diabetes mellitus and macrovascular disease. Metabolism 1996; 45: 133–5.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Takayama S, Itou T, Owada K, Omori Y. Effect of glycemic control on vitamin B12 metabolism in diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 13–17.
   Google Scholar
• Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW. Total homocysteine is associated with nephropathy in non-insulin dependent diabetes mellitus. Metabolism 1999; 48: 1096–101.
   Google Scholar
• Straub RH, Rokitzli L, Schumacher T, Hallmann C, Palitzsch KD, Scholmerich J. Patients with type II diabetes mellitus and neuropathy have no deficiency of vitamins A, E, beta-carotene, B1, B2, B6, B12 and folic acid. Med Klin 1993; 88: 453–7.
   Google Scholar
• Homocysteine Trialist’s Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J 1998; 316: 894–8.
   Google Scholar
• Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non- insulin dependent diabetes mellitus: effect of parenteral methylcobalamine treatment. Athero- sclerosis 1993; 103: 149–57.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Willett WC, Hu FB et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 1998; 279: 359–64.
   Google Scholar
• Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B(12), and vitamin B(6) on clinical outcome after percutaneous coronary intervention: the Swiss Heart Study: a randomized controlled trial. J Am Med Assoc 2002; 288: 973–9.
   PubMed Web of Science ®Google Scholar
• Hoogeven EK, Kostense PJ, Jakobs C et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoom study. Circulation 2000; 101: 1506–11.
   Google Scholar
• Harman LS, Mottley C, Mason RF. Free radical metabolites of L-cysteine oxidation. J Biol Chem 1984; 259: 5606–11.
   PubMed Web of Science ®Google Scholar
• Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980; 18: 113–21.
   PubMed Web of Science ®Google Scholar